| 2025 |
Thompson, E. J., Dorward, E. L., Jurrius, K., Nataren, N., Tondl, M., Myo Min, K. K., . . . Bonder, C. S. (2025). Inhibitor of DNA binding-1 is a key regulator of cancer cell vasculogenic mimicry. Molecular Oncology, online(9), 1-20.
DOI Scopus2 WoS2 Europe PMC1 |
| 2023 |
Myo Min, K. K., Ffrench, C. B., Jessup, C. F., Shepherdson, M., Barreto, S. G., & Bonder, C. S. (2023). Overcoming the Fibrotic Fortress in Pancreatic Ductal Adenocarcinoma: Challenges and Opportunities. Cancers, 15(8), 1-19.
DOI Scopus13 WoS15 Europe PMC13 |
| 2023 |
Myo Min, K. K., Ffrench, C. B., McClure, B. J., Ortiz, M., Dorward, E. L., Samuel, M. S., . . . Bonder, C. S. (2023). Desmoglein-2 as a cancer modulator: friend or foe?. Frontiers in Oncology, 13(1327478), 1327478-1-1327478-15.
DOI Scopus10 WoS11 Europe PMC9 |
| 2022 |
Tan, L. Y., Cockshell, M. P., Moore, E., Myo Min, K. K., Ortiz, M., Johan, M. Z., . . . Bonder, C. S. (2022). Vasculogenic mimicry structures in melanoma support the recruitment of monocytes. OncoImmunology, 11(1), e2043673-1-e2043673-18.
DOI Scopus18 WoS19 Europe PMC19 |
| 2022 |
Myo Min, K. K., Rojas-Canales, D., Penko, D., DeNichilo, M., Cockshell, M. P., Ffrench, C. B., . . . Bonder, C. S. (2022). Desmoglein-2 is important for islet function and β-cell survival. Cell Death and Disease, 13(10), 911-1-911-15.
DOI Scopus7 WoS7 Europe PMC6 |
| 2022 |
Ebert, L. M., Vandyke, K., Johan, M. Z., DeNichilo, M., Tan, L. Y., Myo Min, K. K., . . . Bonder, C. S. (2022). Desmoglein-2 expression is an independent predictor of poor prognosis patients with multiple myeloma. Molecular Oncology, 16(6), 1221-1240.
DOI Scopus11 WoS12 Europe PMC11 |
| 2021 |
Fouladzadeh, A., Dorraki, M., Min, K. K. M., Cockshell, M. P., Thompson, E. J., Verjans, J. W., . . . Abbott, D. (2021). The development of tumour vascular networks. Communications Biology, 4(1, article no. 1111), 1111-1-1111-10.
DOI Scopus20 WoS16 Europe PMC16 |
| 2017 |
Rojas-Canales, D., Penko, D., Min, K., Parham, K., Peiris, H., Haberberger, R., . . . Jessup, C. (2017). Local sphingosine kinase 1 activity improves islet transplantation. Diabetes, 66(5), 1301-1311.
DOI Scopus7 WoS7 Europe PMC4 |
| 2016 |
Ebert, L. M., Tan, L. Y., Johan, M. Z., Min, K. K. M., Cockshell, M. P., Parham, K. A., . . . Bonder, C. S. (2016). A non-canonical role for desmoglein-2 in endothelial cells: implications for neoangiogenesis. Angiogenesis, 19(4), 463-486.
DOI Scopus38 WoS39 Europe PMC30 |
